Expert Interview
Discussing what's next for Regeneron's high dose Eylea post CRL, current trend of Vabysmo, biosimilars and reimbursement.
Ticker(s): REGN, RHHBYInstitution: UC Davis
- Professor of Ophthalmology at UC Davis.
- Manages ~400 patients with wet-AMD.
- Leads a translational research program studying age-related macular degeneration (AMD) and other retinal diseases.
- Research focuses include ocular imaging technologies, gene editing and delivery, and animal models of retinal disease.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
